Soleymanpour K, Hosseini-Karkaj K, Golestani A, Ghahremani Z, Jafari-Sales A, Pashazadeh M. A comprehensive overview of the global impact of brucellosis, its transmission routes and management strategies. Zoonosis 2023; 3 (3) :35-47
URL:
http://zoonosis.ir/article-1-93-en.html
, mehrdadpashazadeh85@gmail.com
Abstract: (961 Views)
Brucellosis is one of the most common bacterial diseases affecting both humans and animals. The World Health Organization (WHO) classifies brucellosis—caused by Brucella species—as a zoonotic disease. Among the most prevalent species are Brucella melitensis (B. melitensis) and Brucella suis (B. suis), with B. suis being less common in Iran compared to other species. Human brucellosis is a systemic infection characterized by a broad spectrum of non-specific symptoms and the potential to affect multiple organs and tissues. The disease remains endemic in many developing regions, including the Middle East, Asia, Africa, and South America. Despite advancements in medical science, the diagnosis and treatment of brucellosis remain significant challenges. Accurate diagnosis requires a combination of clinical evaluation and laboratory methods, including serological, microbiological, and molecular techniques. Given the absence of an effective human vaccine, animal vaccination remains a key strategy for preventing and controlling the spread of the disease. Additionally, proper hygiene and caution in the consumption of dairy products are essential preventive measures. Considering the widespread prevalence of brucellosis in developing countries and its impact on public health and livestock, this study aims to provide a comprehensive review of the transmission routes of brucellosis from animals to humans, along with current strategies for its prevention and treatment.
Book Review:
Review Article |
Subject:
Infectious Disease Received: 2024/09/20 | Accepted: 2024/12/6 | Published: 2025/07/24